Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives;Métrorragies sous contraceptifs: Attitude thérapeutique

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 37, Issue 8 SUPPL. 1, 2008, Pages

  Gompel, A ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Minipill; Oral contraceptives; Progestin IUD Mirena ; Progestin only pill

Indexed keywords

ANTIFIBRINOLYTIC AGENT; CHLORMADINONE ACETATE; CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; CONTRACEPTIVE AGENT; CYPROTERONE ACETATE; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE; ESTROGEN DERIVATIVE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ETHINYLESTRADIOL PLUS NORGESTREL; ETONOGESTREL; LEVONORGESTREL; LYNESTRENOL; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; NOMEGESTROL ACETATE; NORETHISTERONE; NORETHISTERONE ACETATE; PLACEBO; PROGESTERONE DERIVATIVE; PROMEGESTONE; RUSCUS ACULEATUS EXTRACT; UNINDEXED DRUG; ZIPEPROL; ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

BLEEDING; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; METRORRHAGIA; PREGNANCY; REVIEW; SPOTTING; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG IMPLANT; FEMALE; INTRADERMAL DRUG ADMINISTRATION; UTERUS BLEEDING;

ADMINISTRATION, CUTANEOUS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; DRUG IMPLANTS; ESTROGENS; FEMALE; HUMANS; LEVONORGESTREL; METRORRHAGIA; PROGESTINS; UTERINE HEMORRHAGE;

EID: 69849114490     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0368-2315(08)74776-8     Document Type: Article

References (46)

1. Louv WC, Austin H, Perlman J, et al. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989;160:396-402. (Pubitemid 19065383)
2. Hickey M, Krikun G, Kodaman P, et al. Long-term progestinonly contraceptives result in reduced endometrial blood flow and oxidative stress. J Clin Endocrinol Metab 2006;91:3633-3638 (Pubitemid 44402148)
3. Lockwood CJ, Krikun G, Rahman M, et al. The role of decidualization in regulating endometrial hemostasis during the mens trual cycle, gestation, and in pathological states. Semin Thromb Hemost 2007;33:111-117 (Pubitemid 46184038)
4. Lockwood CJ, Schatz F, Krikun G. Angiogenic factors and the endometrium following long term progestin only contraception. Histol Histopathol 2004;19:167-172 (Pubitemid 38111261)
5. Collins J, Crosignani PG. Endometrial bleeding. Hum Reprod Update 2007;13:421-431
6. Maitra N KR, Bloemenkamp KWM, Helmerhorst FM, Gülmezoglu AM. Progestogens in combined oral contraceptives for contraception (Review). Cochrane Database Syst Rev 2004:1-75.
7. Van Vliet HA, Grimes DA, Lopez LM, et al. Triphasic versus monophasic oral contraceptives for contraception. Cochrane Database Syst Rev 2006;3:CD003553.
8. Van Vliet HA, Grimes DA, Helmerhorst FM, et al. Biphasic versus triphasic oral contraceptives for contraception. Cochrane Database Syst Rev 2006;3:CD003283.
9. Bachmann G, Korner P. Bleeding patterns associated with oral contraceptive use: a review of the literature. Contraception 2007;76:182-189 (Pubitemid 47260594)
10. Sabatini R, Orsini G, Cagiano R, et al. Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents. Contraception 2007;76:342-347 (Pubitemid 47600123)
11. Edelman AB, Koontz SL, Nichols MD, et al. Continuous Oral Contraceptives: Are Bleeding Patterns Dependent on the Hormones Given? Obstet Gynecol 2006;107:657-665.
12. Legro RS, Pauli JG, Kunselman AR, et al. Effects of continuous versus cyclical oral contraception: a randomized controlled trial. J Clin Endocrinol Metab 2008;93:420-429 (Pubitemid 351240811)
13. Edelman AB GM, Jensen JT, Nichols MD, Schulz KF, Grimes DA. Continuous or extended cycle versus cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev 2008:CD004695.
14. Kwiecien MEA, Nichols MD, Jensen JT. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 2003;67:9-13.
15. Lopez LM GD, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 2008:CD003552.
16. Anonymous. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill. Eur J Contracept Reprod Health Care 1998;3:169-178
17. Power J FR, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. The Cochrane Library 2008.
18. Datey S, Gaur LN, Saxena BN. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills) an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research. Contraception 1995;51:155-165
19. Hickey M, Fraser IS. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding. Hum Reprod 2002;17:2428-2434
20. Lau TM, Witjaksono J, Rogers PA. Progesterone receptor in Norplant endometrium. Hum Reprod 1996;11 Suppl 2:90-94
21. Rogers PA. Endometrial vasculature in Norplant users. Hum Reprod 1996;11 Suppl 2:45-50.
22. Faundes A, Alvarez-Sanchez F, Brache V, et al. Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant subdermal implants. Adv Contracept 1991;7:85-94.
23. Lethaby AE CI, Rees M Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005:CD002126.
24. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78:716-721
25. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56-72. (Pubitemid 24077388)
26. Rosenberg MJ, Waugh MS, Stevens CM. Smoking and cycle control among oral contraceptive users. Am J Obstet Gynecol 1996;174:628-632 (Pubitemid 26070155)
27. Pfrunder A, Schiesser M, Gerber S, et al. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol 2003;56:683-690 (Pubitemid 37491722)
28. Murphy PA, Kern SE, Stanczyk FZ, et al. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005;71:402-408
29. Dickinson BD, Altman RD, Nielsen NH, et al. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001;98:853-860 (Pubitemid 33042558)
30. Abdel-Aleem H, d'Arcangues C, Vogelsong K, et al. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 2007:CD003449.
31. Johannisson E, Landgren BM, Diczfalusy E. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 microgram norethisterone (NET) minipill. Contraception 1982;25:13-30. (Pubitemid 12222220)
32. Gemzell-Danielsson K, van Heusden AM, Killick SR, et al. Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen. Hum Reprod 2002;17:2588-2593 (Pubitemid 35174109)
33. Monteil-Seurin J, Bernard-Fernier MF, Martinaggi P, et al. [Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception]. Contracept Fertil Sex (Paris) 1985;13:721-725
34. Faundes A, Alvarez F, Brache V, et al. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants. Hum Reprod 1998;13:188-191 (Pubitemid 28075299)
35. Boonkasemsanti W, Reinprayoon D, Pruksananonda K, et al. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users. Hum Reprod 1996;11 Suppl 2:115-123
36. Diaz S, Croxatto HB, Pavez M, et al. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 1990;42:97-109. (Pubitemid 20208814)
37. Witjaksono J, Lau TM, Affandi B, et al. Oestrogen treatment for increased bleeding in Norplant users: preliminary results. Hum Reprod 1996;11 Suppl 2:109-114
38. Alvarez-Sanchez F, Brache V, Thevenin F, et al. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 1996;174:919-922 (Pubitemid 26111671)
39. Weisberg E, Hickey M, Palmer D, et al. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 2006;21:295-302. (Pubitemid 41794324)
40. Cheng L, Zhu H, Wang A, et al. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 2000;15:1969-1972 (Pubitemid 30686164)
41. Massai MR, Pavez M, Fuentealba B, et al. Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users. Contraception 2004;70:47-54. (Pubitemid 38781978)
42. Kaewrudee S, Taneepanichskul S, Jaisamraun U, et al. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use. Contraception 1999;60:25-30. (Pubitemid 29505352)
43. Phupong V, Sophonsritsuk A, Taneepanichskul S. The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use. Contraception 2006;73:253-256 (Pubitemid 43202175)
44. Abdel-Aleem H, Shaaban OM, Amin AF, et al. Tamoxifen treatment of bleeding irregularities associated with Norplant use. Contraception 2005;72:432-437 (Pubitemid 41679344)
45. Gompel A, Carpentier S, Frances C, et al. Risk of venous thromboembolism and oral contraceptives. Lancet 2002;359:1348-1349
46. Intrauterine devices and intrauterine systems. Hum Reprod Update 2008;14:197-208.